Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

CEBM members and affiliates who are part of the Oxford Tobacco Addiction Group team (OxTAG) shared their smoking/vaping cessation research work at the annual Society for Research on Nicotine and Tobacco (SRNT) conference in New Orleans earlier this month.

From left to right Monserrat Conde, Annika Theodoulou, Nicola Lindson, Andrea Leinberger-Jabari and Ailsa Butler

Oxford academics and members of OxTAGNicola LindsonMonserrat Conde and Ailsa Butler, along with DPhil in Evidence-Based Health Care students Andrea Leinberger-Jabari and Annika Theodoulou, gave 12 presentations/posters at the event, sharing many strands of their work including their new review of interventions to quit vaping, and their widely cited e-cigarettes for smoking cessation review  - more details here. Also included was their new evidence and gap maps for both the reviews and an overview of reviews, further ways to share information to all stakeholders. Along with this they presented work on the role of flavours to help people to quit; a service evaluation of very brief advice for smoking cessation for people accessing financial services living in social housing; and the essential elements of culturally tailoring interventions.

The SRNT conference is the most important meeting of the year for tobacco and nicotine research, and gave the team the opportunity to meet with other researchers, and discuss important elements of study design including longer term follow-up and assessing measures of harm. This was especially important with pilot trials, allowing adaptations to be incorporated into the full randomised controlled trials. This will strengthen the information base for the team's Cochrane reviews.

Find more information about OxTAG, including podcasts and publications here:

 QR code